DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of “Reduce” from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has earned an average rating of “Reduce” from the fifteen analysts that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $15.1538.

Several analysts recently weighed in on XRAY shares. Zacks Research lowered DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. UBS Group lowered their price target on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a report on Tuesday, October 28th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.52% of the stock is owned by corporate insiders.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently made changes to their positions in the stock. Trust Co. of Toledo NA OH bought a new position in DENTSPLY SIRONA during the 2nd quarter worth $27,000. Parkside Financial Bank & Trust boosted its holdings in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,477 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of DENTSPLY SIRONA during the first quarter worth about $26,000. True Wealth Design LLC increased its holdings in shares of DENTSPLY SIRONA by 273.0% in the 2nd quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after acquiring an additional 1,739 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,122 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 1.3%

XRAY stock opened at $11.39 on Friday. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36. The firm has a 50 day simple moving average of $11.47 and a 200-day simple moving average of $13.34. The company has a market capitalization of $2.27 billion, a P/E ratio of -2.58, a PEG ratio of 0.82 and a beta of 1.01. DENTSPLY SIRONA has a twelve month low of $9.85 and a twelve month high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The company’s revenue was down 4.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, equities research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 9th. Investors of record on Friday, December 26th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, December 26th. This represents a $0.64 annualized dividend and a yield of 5.6%. DENTSPLY SIRONA’s dividend payout ratio is -14.48%.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.